· Op-Ed/Commentary
COVID-19Intellectual Property The Neanderthal Protectionists at the Washington Post Don’t Care About Getting the World VaccinatedDean Baker / May 04, 2021
· Op-Ed/Commentary
COVID-19InequalityIntellectual Property Patents and the Pandemic: Can We Learn Anything?Dean Baker / April 12, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryIntellectual Property A Vaccine Summit: Taking the Pandemic SeriouslyDean Baker / April 09, 2021
· report
COVID-19Health and Social ProgramsInequalityUnited States Housing Insecurity by Race and Place During the PandemicJulie Yixia CaiShawn FremstadSimran Kalkat / April 05, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and Recovery The March Jobs Report and the State of the RecoveryDean Baker / April 04, 2021
· Op-Ed/Commentary
BrazilCOVID-19Latin America and the CaribbeanUnited StatesUS Foreign Policy In Brazil, Vaccine Diplomacy Can Help Save the ClimateJustin Talbot Zorn / FOREIGN POLICY / March 30, 2021
· Op-Ed/Commentary
COVID-19InequalityIntellectual Property New York Times Does Public Relations Work for the Pharmaceutical IndustryDean Baker / March 21, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryIntellectual Property Thomas Cueni, Director General of the International Pharma Trade Association, Calls Bill Gates a MoronDean Baker / March 17, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryInequalityIntellectual Property The New York Times Has not Heard of China’s (or Russia’s) VaccinesDean Baker / March 04, 2021
· Op-Ed/Commentary
COVID-19Economic Crisis and RecoveryIntellectual Property To Prevent the Resurgence of the Pandemic, Can We Talk About Open-Source Research?Dean Baker / February 26, 2021